Peer-Reviewed Literature Synthesis

Hypertension Biomarker Atlas

Molecular alterations reported in Hypertension compared to healthy controls, from peer-reviewed literature.

Literature Overview

Biomarkers below are included only where peer-reviewed literature explicitly reports the marker's direction in Hypertension patients relative to a named comparison population — not inferred.

3
Curated markers
3
Categories

Searchable Alterations Database

Comparison populations are quoted as reported in the source literature (e.g. healthy controls, disease-matched patients).

Marker / TestDirectionCategoryvs. ComparisonClinical ContextKey Reference

Key References

Peer-Reviewed Literature

Tomaschitz et al. 2010

DOI: 10.1038/nrendo.2009.263 →
Peer-Reviewed Literature

Bayes-Genis et al. 2023

DOI: 10.1002/ejhf.3036 →
Peer-Reviewed Literature

Ishikawa et al. 2010

DOI: 10.1111/j.1751-7176.2010.00286.x →
Disclaimer: Educational synthesis of peer-reviewed literature only — not medical advice. Markers are drawn from published disease-vs-comparison-population studies; inclusion here does not imply diagnostic or clinical validation. Consult a qualified healthcare professional for interpretation.

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.